HomeNRX • CVE
add
Nurexone Biologic Inc
Nakaraang pagsara
$0.71
Sakop ng araw
$0.69 - $0.69
Sakop ng taon
$0.46 - $0.87
Market cap
53.66M CAD
Average na Volume
14.41K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Mga balita tungkol sa merkado
Bloomberg.com
2 oras ang nakalipas
Bear Market Is Coming With S&P 500 Rally Stalling Soon, DeMark Says
1.52%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 1.48M | 107.26% |
Net na kita | -1.55M | -109.77% |
Net profit margin | — | — |
Kita sa bawat share | -0.02 | — |
EBITDA | -1.47M | -106.45% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 700.00K | 29.39% |
Kabuuang asset | 2.44M | 12.49% |
Kabuuang sagutin | 680.00K | -65.67% |
Kabuuang equity | 1.76M | — |
Natitirang share | 78.01M | — |
Presyo para makapag-book | 35.50 | — |
Return on assets | -122.54% | — |
Return on capital | -156.11% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.55M | -109.77% |
Cash mula sa mga operasyon | -1.74M | -174.09% |
Cash mula sa pag-invest | -45.00K | -2.27% |
Cash mula sa financing | 177.00K | 96.67% |
Net change in cash | -1.82M | -202.82% |
Malayang cash flow | -1.31M | 16.13% |
Tungkol
Itinatag
2011
Website
Mga Empleyado
12
